Viewing StudyNCT05772624



Ignite Creation Date: 2024-05-06 @ 6:46 PM
Last Modification Date: 2024-10-26 @ 2:54 PM
Study NCT ID: NCT05772624
Status: RECRUITING
Last Update Posted: 2023-03-16
First Post: 2023-02-13

Brief Title: Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkins Lymphoma
Sponsor: Hospital Universitario Dr Jose E Gonzalez
Organization: Hospital Universitario Dr Jose E Gonzalez

Conditions & Keywords Data

Conditions:
Name
Safety Issues
Efficacy Self
Keywords:
Name View
Nivolumab View
lowdose nivolumab View
NAVD View
hodgkins lymphoma View